학술논문
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage
Document Type
article
Author
Pietro Carotenuto; Francesco Amato; Andrea Lampis; Colin Rae; Somaieh Hedayat; Maria C. Previdi; Domenico Zito; Maya Raj; Vincenza Guzzardo; Francesco Sclafani; Andrea Lanese; Claudia Parisi; Caterina Vicentini; Ian Said-Huntingford; Jens C. Hahne; Albert Hallsworth; Vladimir Kirkin; Kate Young; Ruwaida Begum; Andrew Wotherspoon; Kyriakos Kouvelakis; Sergio Xavier Azevedo; Vasiliki Michalarea; Rosie Upstill-Goddard; Sheela Rao; David Watkins; Naureen Starling; Anguraj Sadanandam; David K. Chang; Andrew V. Biankin; Nigel B. Jamieson; Aldo Scarpa; David Cunningham; Ian Chau; Paul Workman; Matteo Fassan; Nicola Valeri; Chiara Braconi
Source
Nature Communications, Vol 12, Iss 1, Pp 1-14 (2021)
Subject
Language
English
ISSN
2041-1723
Abstract
Understanding which patients will respond to FOLFIRINOX therapy is important for clinical outcome. Here, the authors show that the MIR1307 is increased pancreatic cancer cell lines and inhibition of the microRNA sensitises cells to treatment.’ stratifying patients to achieve the best clinical outcome. Here, the authors show that the MIR1307 is increased in a subgroup of human pancreatic cancers and inhibition of the microRNA in in vitro and in vivo models of pancreatic cancer sensitises cells to treatment.